Search

Displaying results 7251 - 7260 of 10000 in total
  1. Drug

    Poliomyelitis virus type 3 (live, attenuated)

    go.drugbank.com/drugs/DB16579
    Investigational

    Mixtures: POLIO SABIN ONE AND THREE (ORAL) VACCINE
  2. Drug

    Burfiralimab

    go.drugbank.com/drugs/DB18935
    Investigational

    Burfiralimab is under investigation in clinical trial NCT06306339 (A Study to Assess the Efficacy and Safety of Burfiralimab (Hzvsf-v13) and DMRD (Disease-modifying Antirheumatic Drug)).

  3. Drug

    Lobaplatin

    go.drugbank.com/drugs/DB13049
    Investigational

    Lobaplatin has been used in trials studying the treatment of Breast Cancer, Hepatocellular Carcinoma, and Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma.

  4. Drug

    Danirixin

    go.drugbank.com/drugs/DB11922
    Investigational

    Danirixin has been used in trials studying the treatment and basic science of Virus Diseases, Nutritional Status, Pulmonary Disease, Chronic Obstructive, and Infections, Respiratory Syncytial Virus.

  5. Drug

    Savolitinib

    go.drugbank.com/drugs/DB12048
    Investigational

    Savolitinib has been used in trials studying the treatment and health services research of Tumor, Food Effect, Gastric Cancer, Health Subjects, and Colorectal Cancer, among others.

  6. Drug

    Taselisib

    go.drugbank.com/drugs/DB12108
    Investigational

    Taselisib has been used in trials studying the treatment and basic science of LYMPHOMA, Breast Cancer, Ovarian Cancer, Solid Neoplasm, and HER2/Neu Negative, among others.

  7. Drug

    Allocetra

    go.drugbank.com/drugs/DB16424
    Investigational

    With infusion, the body's macrophages and dendritic cells can feed on these early apoptotic Allocetra cells and thus result in the macrophages and dendritic cells releasing fewer cytokine alert signals … This drug is currently being investigated against organ failure associated with sepsis, organ failure associated with COVID-19, post-bone marrow transplantation complications, and solid tumors.

  8. Drug

    VE303

    go.drugbank.com/drugs/DB17794
    Investigational

    VE303 is under clinical development by Vedanta Biosciences.

  9. Drug

    Glovadalen

    go.drugbank.com/drugs/DB21709
    Investigational

    Glovadalen is under investigation in clinical trial NCT06970301 (A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants)

  10. Drug

    RGX-181

    go.drugbank.com/drugs/DB17942
    Experimental

    RGX-181 consists of an adeno-associated virus serotype 9 (AAV9) vector designed to deliver the soluble lysosomal enzyme tripeptidyl peptidase I (TPP1) gene. … Developed by REGENXBIO, it is being investigated for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease.[L47072]